Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V I Reus

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Archives of General Psychiatry|April 1, 1976
The development of criteria for evaluating psychiatric education programsJ S Eaton, M R Haas, A S Abraham, et al.
The American Journal of Psychiatry|August 1, 1996
Dexamethasone for depressionO M Wolkowitz, V I Reus, F Manfredi, et al.
The American Journal of Psychiatry|October 1, 1981
Heterogeneity of amphetamine response in depressed patientsE K Silberman, V I Reus, D C Jimerson, et al.
The American Journal of Psychiatry|April 14, 1999
Double-blind treatment of major depression with dehydroepiandrosteroneO M Wolkowitz, V I Reus, A Keebler, et al.
Biological Psychiatry|April 21, 1998
Cortisol and response to dexamethasone as predictors of withdrawal distress and abstinence success in smokersS L Frederick, V I Reus, D Ginsberg, et al.
Annals of the New York Academy of Sciences|January 1, 1982
Role of opioid peptides in disorders of attention in psychopathologyM S Buchsbaum, V I Reus, G C Davis, et al.
Biological Psychiatry|July 1, 1999
Antiglucocorticoid treatment of depression: double-blind ketoconazoleO M Wolkowitz, V I Reus, T Chan, et al.
Biological Psychiatry|September 7, 2001
Cortisol levels predict cognitive impairment induced by electroconvulsive therapyT C Neylan, J D Canick, S E Hall, et al.
The American Journal of Psychiatry|March 4, 2000
Development of major depression after treatment for smoking cessationJ Y Tsoh, G L Humfleet, R F Muñoz, et al.
The American Journal of Psychiatry|October 1, 1990
Cognitive effects of corticosteroidsO M Wolkowitz, V I Reus, H Weingartner, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Archives of General Psychiatry|April 1, 1976
The development of criteria for evaluating psychiatric education programsJ S Eaton, M R Haas, A S Abraham, et al.
The American Journal of Psychiatry|August 1, 1996
Dexamethasone for depressionO M Wolkowitz, V I Reus, F Manfredi, et al.
The American Journal of Psychiatry|October 1, 1981
Heterogeneity of amphetamine response in depressed patientsE K Silberman, V I Reus, D C Jimerson, et al.
The American Journal of Psychiatry|April 14, 1999
Double-blind treatment of major depression with dehydroepiandrosteroneO M Wolkowitz, V I Reus, A Keebler, et al.
Biological Psychiatry|April 21, 1998
Cortisol and response to dexamethasone as predictors of withdrawal distress and abstinence success in smokersS L Frederick, V I Reus, D Ginsberg, et al.
Annals of the New York Academy of Sciences|January 1, 1982
Role of opioid peptides in disorders of attention in psychopathologyM S Buchsbaum, V I Reus, G C Davis, et al.
Biological Psychiatry|July 1, 1999
Antiglucocorticoid treatment of depression: double-blind ketoconazoleO M Wolkowitz, V I Reus, T Chan, et al.
Biological Psychiatry|September 7, 2001
Cortisol levels predict cognitive impairment induced by electroconvulsive therapyT C Neylan, J D Canick, S E Hall, et al.
The American Journal of Psychiatry|March 4, 2000
Development of major depression after treatment for smoking cessationJ Y Tsoh, G L Humfleet, R F Muñoz, et al.
The American Journal of Psychiatry|October 1, 1990
Cognitive effects of corticosteroidsO M Wolkowitz, V I Reus, H Weingartner, et al.
Pageof 10